CHERRY CREEK RESEARCH INC. CLINICAL RESEARCH COMPLETED PRINCIPAL INVESTIGATOR- J. MICHAEL MALONEY III, MD
|
|
|
- Timothy Lloyd
- 6 years ago
- Views:
Transcription
1 CLINICAL STUDY CHERRY CREEK RESEARCH INC. CLINICAL RESEARCH COMPLETED PRINCIPAL INVESTIGATOR- J. MICHAEL MALONEY III, MD SUB-P.I. STUDY Rosacea, Topical, , (Galderma), Multicenter, Open- Label study for subjects with moderate to severe rosacea Acne, Topical, , (Perrigo), Randomized, Doubleblind, parallel-group of patient with moderate to severe acne vulgaris Psoriasis,Injectable, (Abbott), A Phase 3, Multicenter, Randomized, Double-blind, Placebo- Controlled study of subjects with moderate to severe plaquetype psoriasis Psoriasis, Injectable, (Jansen),A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled trial of subjects with moderate to severe plaque-type psoriasis /Cara Shepherd /Pia Andersson /Pia Andersson /John Bradt, John Bradt, Psoriasis, Oral (Pfizer) A phase 3, multi-site, randomized, double-blind,
2 placebo-controlled, parallelgroup study of subjects with moderate to severe chronic plaque psoriasis Acne, Topical 2011 (Tolmar) A double-blind, randomized, parallel-design, Vehiclecontrolled, multicenter trial in the treatment of acne vulgaris Rosacea, Topical 2011 (Galderma) A Multicenter, Open-Label study in subjects with moderate to severe facial erythema associated with Rosacea Psoriasis, Topical 2010 (Stiefel) A Multicenter, Randomized, Double-Blind Study in the treatment of moderate plaquetype scalp and body psoriasis Acne, Topical, 2010 (Stiefel, a GSK Company) A Phase 3 Multicenter, Randomized, double-blind, Active and Vehicle-Controlled Study in subjects with acne vulgaris Nikki Cara/ Actinic Keratosis, Topical, 2009 Amy Starkweather
3 (Tolmar/Clinsys) A Double-Blind, Randomized, Parallel-Group, Vehicle- Controlled, Multicenter Study of Actinic Keratosis. Rosacea, Topical and Oral, 2009 (TKL/Intendis) Acne, Topical, 2008 (STIEFEL) Acne, Oral, 2008 (DOW) Actinic Keratosis., Topical, 2008 (ACTIVAS) Psoriasis, Injectable, 2008 (ABBOTT) Psoriasis, Injectable, 2008 (ABBOTT) Psoriasis, Topical, 2008 (STIEFEL) Cara Magee, Cara Magee, Cara Magee, Protocol Amy Starkweather Amy Starkweather, Amy Starkweather, Amy Starkweather, Amy Starkweather, Psoriasis, Topical, 2008 (COLLAGENEX) Rosacea, Topical, 2008 (INTENDIS) Acne, Topical, 2008 (DOW/GALDERMA) Cara Magee,, Amanda Newell, Amanda Newell
4 Rosacea, Topical, 2008 (DOW) Rosacea, Topical, 2007 (PERRIGO) Acne, Levulan stick- Topical, 2007 (DUSA) Psoriasis, Topical, 2007 (THERAPEUTICS) Acne, Topical, 2006 (DOW) Acne, Topical, 2006 (GALDERMA) Psoriasis, Topical, 2006 (ASTELLAS) Psoriasis, Topical, 2006 (VITAE) Psoriasis, Injectable, 2006 (CENTOCOR) Acne, Topical, 2005 (QLT-USA) Acne, Topical, 2005 (MEDICIS) Seborrheic Dermatitis, Topical, 2005, (CONNECTICS) Rosacea, Topical, 2005 (QLT-USA) Psoriasis, Subcutaneous, 2004 (SERONO) Psoriasis, Oral, 2004 (SYNTA) Cara Magee,, Amanda Newell Cara Magee, John Bradt Cara Magee,, Wendy Suchey, Wendy Suchey, Wendy Suchey, Wendy Suchey, Wendy Suchey, John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt John Bradt
5 Rosacea, Topical, 2004 Wendy Suchey, (BERLEX) Psoriasis, Sub Q, 2004 Wendy Suchey, (AMGEN) Rosacea, Topical, 2004 Wendy Suchey, (ATRIX) Atopic Dermatitis, Topical, Wendy Suchey, (DOW) Actinic Keratosis, Topical, Wendy Suchey, Debbie (3M) Horton Psoriasis, Topical, 2004 Wendy Suchey, (FUJISAWA) Seborrheic Dermatitis, Topical, 2004 (BARRIER) Acne, Topical, 2003 Wendy Suchey, (GUNTHY-RENKER) Psoriasis, Subcutaneous, (GENETECH) Psoriasis, IV, 2003 Wendy Suchey, (CENTOCOR) Psoriasis, Subcutaneous, (AMGEN-EDUCATE) Atopic Dermatitis, Topical, (MEDICIS) Psoriasis, F/UP 074, 082, (MEDIMMUNE) Psoriasis, Oral, 2003 (GSK) Acne, Topical, 2003 (ATRIX)
6 Acne, Oral, 2002 (BERLEX) Psoriasis, Oral, 2002 (BIOGEN) Psoriasis, Topical, 2002 (THERAPEUTICS) Psoriasis, Topical, 2002 (FUJISAWA) Rosacea, Topical, 2002 (BERLEX) Psoriasis, Oral, 2002 (ALLERGAN) Psoriasis, Intravenous, 2002 (CENTOCOR) Acne, Topical, 2002 (ATRIX) Psoriasis, Sub Q, 2001 (MEDIMMUNE) Psoriasis, Topical, 2001 (WINSTON) Psoriasis, Intravenous, 2001 (MEDIMMUNE) Acne, Topical, 2001 (PHARMAKINETEC) Psoriasis, Intravenous, 2001 (BIOGEN) Rosacea, Topical, 2001 (BERLEX) Basal Cell Carcinoma Topical, 2001 (3M)
7 Women s Anti-Skin Aging, Oral, 2001 (PARKE- DAVIS) Men s Hair Growth, Topical, 2000 (BMS) Atopic Dermatitis, Topical, 2000, (FUJISAWA) Psoriasis, Intravenous, 2000 (BIOGEN) Acne, Topical, 2000 (ATRIX) Ichthyosis, Topical, 1999 (BRISTOL-MYERS SQUIBB) Skin Infections, Oral, 1998 (TAP HOLDINGS, INC.) Acne, Topical, 1998 (PARKE-DAVES) Psoriasis, Topical, 1998 (STIEFEL) Acne, Topical, 1998 (DERMIK) Atopic Dermatitis, Topical, 1996 (GALDERMA) Acne, Topical, 1996 (DERMIK) Wound Infection, Topical, 1995 (SMITH-KLINE BEECHAM) Acne, Topical, 1995 (ALLERGAN) John Bradt John Bradt John Bradt John Bradt John Bradt
8 Rosacea, Topical, 1995 (GALDERMA) Photo Damaged Skin, Topical, 1995 (BRISTOL- MYERS SQUIBB) Atopic Dermatitis, Topical, 1995 Psoriasis, Topical, 1995 Atopic Dermatitis, Topical, 1994 (CHEMEX) Collagen, Injectable implant, 1994 (COLLAGEN CORP) Psoriasis, Topical, 1994 Solar Lentigines, Topical, 1994 (BRISTOL-MYERS SQUIBB) Dry Skin, Topical, 1994 Atopic Dermatitis., Topical, 1993 (GENDERM) Psoriasis, Topical, 1993 (ALLERGAN) Tinea Corpus, Topical, 1993 (GLAXO) Tinea Unguium, Topical, 1993 (ROCHE) Atopic Dermatitis., Topical, 1993 (GLAXO) 8
9 Ichthyosis Vulgaris, Topical, 1993 (BRISTOL- MYERS SQUIBB) Intralesional Treatment for Conyloma Accuminata, 1993 (SERONO) Acne, Topical, 1993 (DERMIK) Hair Loss in Females, Topical, 1992 (UPJOHN) Impetigo, Topical, 1992 Folliculitis, Topical 1992 Acne, Topical, 1992 (GENDERM) Oral Antibiotic, 1992 (RHONE POULENC RHORER) Atopic Dermatitis., Topical 1992 (GENDERM) Acne, Topical, 1991, (ALLERGAN) Acne, Topical, 1991, SYNTEX) Acne, Topical, 1991 (GENDERM) Acne, Topical, 1990 (GENDERM) Nodular Cystic Acne, Iontophoresis, 1990 (IOMED) 9
10 Photo damaged Skin, Topical, 1989 (ORTHO) Acne, Topical, 1989 (RW JOHNSON PRI) Tinea Pedis, Topical, 1989 (ALLERGAN) Collagen Implants, 1989 (COLLAGEN CORP) Nodular Cystic Acne, Iontophoresis, 1989 (IOMED) Actinic Keratosis, Topical, 1989 (CHEMEX) The Use of Phoressor II in Dermatology, 1988 (COLLAGEN CORP) Actinic Keratosis, Topical, 1988 (CHEMEX) Localized Skin Anesthesia, Iontophoresis, 1988 (IOMED) 10
Douglas N. Robins, M.D. Ameriderm Research
Curriculum Vitae Douglas N. Robins, M.D. Ameriderm Research Office Address: Leavitt Medical Associates of Florida (DBA) Advanced Dermatology and Cosmetic Surgery Ameriderm Research 4100 Southpoint Dr.
Dermatology practice at Aiken Dermatology and Skin Cancer Clinic Aiken, South Carolina July 1989 July 1991
CURRICULUM VITAE DOUGLASS WILLIAM FORSHA, M.D. OFFICE: Jordan Valley Dermatology 3570 West 9000 South, Suite 220 West Jordan, Utah 84088 Phone: (801) 569-1456 Research Direct phone: (801) 316-0266 FAX:
Elizabeth Ann Golden, PA-C
Elizabeth Ann Golden, PA-C Dawes Fretzin Clinical Research Group, LLC Dawes Fretzin Dermatology Group, LLC 8103 Clearvista Parkway, Suite 260 8103 Clearvista Parkway, Suite 220 Indianapolis, Indiana 46256
SUNDAY, JAN 15 Coordinating Care to Improve Outcomes in Patients with Psoriatic Arthritis
SUNDAY, JAN 15 Coordinating Care to Improve Outcomes in Patients with Psoriatic Arthritis National Doral, Miami, Florida 7:20 AM 8:20 AM, Ballroom B For more information about this no fee symposium visit
DESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S
Regardless of your future field of practice, you will be exposed to a considerable amount of dermatology and this rotation provides you the chance to see a range of skin diseases. You will have the opportunity
PO Box 1079 Litchfield, CT ( Semi-Annual Education Program. January 9, 2009 The Aqua Turf Club Plantsville, Connecticut
PO Box 1079 Litchfield, CT 06759 (860 567-4911 CONNECTICUT SEMI-ANNUAL DERMATOLOGY SCIENTIFIC AND DERMATOLOGIC EDUCATION SURGERY PROGRAM SOCIETY Physicians November - Management 1, 2012 - Technicians Semi-Annual
Tazorac (tazarotene), Fabior (tazarotene), tazarotene powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.02 Subject: Tazarotene Page: 1 of 5 Last Review Date: September 15, 2017 Tazarotene Description Tazorac
Scott T. Guenthner M.D. The Indiana Clinical Trials Center, PC 824 Edwards Drive, Suite 172 Plainfield, Indiana Phone: (317)
PROFESSIONAL EXPERIENCE: Scott T. Guenthner M.D. The Indiana Clinical Trials Center, PC 824 Edwards Drive, Suite 172 Plainfield, Indiana 46168 Phone: (317) 837-6082 03/2006 Present President/CEO/Principle
CURRICULUM VITAE. Steven K. Grekin, D.O., F.A.O.C.D. Board Certified in Dermatology
CURRICULUM VITAE Steven K. Grekin, D.O., F.A.O.C.D. Board Certified in Dermatology Grekin Skin Institute 13450 East Twelve Mile Road Warren, Michigan 48088 586-759-5525 Fax 586-759-4765 EDUCATION 1985-1989
Presented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX
Evaluation of the Efficacy, Safety and Tolerability of 4% Once-Daily in Subjects with Moderate to Severe Acne Vulgaris Treated Topically for Up to 52 Weeks A Hebert, J Del Rosso, M Rico, R Woolson, E de
The Nail Psoriasis Severity Index (NAPSI): Validation of an Instrument to Assess Psoriatic Nail Involvement
The Nail Psoriasis Severity Index (NAPSI): Validation of an Instrument to Assess Psoriatic Nail Involvement Julie Jefferson 1, Racheal Manhart 2, Jill Moore 3 Richard Scher 4, Phoebe Rich 5 1Dermatology,
Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
Regulatory Status FDA approved indication: Tretinoin products are indicated for the topical treatment of acne vulgaris (5-16).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.03 Subject: Tretinoin Page: 1 of 5 Last Review Date: September 15, 2017 Tretinoin Description Atralin
Dana Kazlow Stern. Emory University, Atlanta, Georgia Summa Cum Laude Bachelor of Science, May, 1998 Major: Human Biology & Anthropology
Dana Kazlow Stern Education New York Medical College, Valhalla, New York August, 1998 2002 Emory University, Atlanta, Georgia Summa Cum Laude Bachelor of Science, May, 1998 Major: Human Biology & Anthropology
Table of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne
Table of Contents: Part 1 Medical Dermatology Chapter 1 Acneiform Disorders Acne Acne Vulgaris Pomade Acne Steroid Acne Infantile Acne Pediatric Perspectives Neonatal Acne (Acne Neonatorum) Pediatric Perspectives
CURRICULUM VITAE SUNIL S. DHAWAN, M.D.
CURRICULUM VITAE SUNIL S. DHAWAN, M.D. OFFICE: (510) 797-4111, (408) 957-7676 DATE OF BIRTH: April 17, 1959 PLACE OF BIRTH: UNDERGRADUATE EDUCATION: MEDICAL EDUCATION: POSTGRADUATE EDUCATION: London, England
Telemedicine evaluation of cutaneous diseases: A blinded comparative study
Telemedicine evaluation of cutaneous diseases: A blinded comparative study Jack L. Lesher, Jr., MD, a Loretta S. Davis, MD, a Frederick W. Gourdin, MD, a Debra English, MD, b and William O. Thompson, PhD
Rash Decisions Approach to the patient with a skin condition
National Conference for Nurse Practitioners April 25, 2014 Rash Decisions Approach to the patient with a skin condition Margaret A. Bobonich, DNP, FNP C, DCNP, FAANP Assistant Professor, Case Western Reserve
Tazorac (tazarotene), Fabior (tazarotene), tazarotene powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.14.02 Subject: Tazarotene Page: 1 of 5 Last Review Date: June 12, 2014 Tazarotene Description Tazorac
TODD ERIC SCHLESINGER, MD, FAAD Curriculum Vitae
TODD ERIC SCHLESINGER, MD, FAAD Curriculum Vitae Dermatology & Laser Center of Charleston 1364 Ashley River Rd Charleston, SC 29407 AND 2180 Henry Tecklenburg Drive Charleston, SC 29414 Phone: (843) 556-8886
Kappa P. Meadows, M.D. Born: Tifton, Georgia September 3, 1966 U.S. Citizen Residence: Lynchburg, Virginia License #
Kappa P. Meadows, M.D. Born: Tifton, Georgia September 3, 1966 U.S. Citizen Residence: Lynchburg, Virginia License #0101-225823 Education: Experience: 1999-2000 Faculty, University of Utah, Department
Dermatology GP Referral Guidelines
Austin Health Dermatology Department holds 5 Clinic sessions to discuss and plan the treatment of with Dermatology conditions. Department of Health clinical urgency categories for specialist clinics Urgent:
CLASSIFICATION OF AGA IN MALES: THE HAMILTON-NORWOOD SYSTEM DISCLOSURE OF CONFLICTS OF INTEREST
DISCLOSURE OF CONFLICTS OF INTEREST Investigator: Allergan, Intendis, Procter & Gamble, Abbott, Samumed, Cassiopea, Bayer, Galderma Amy McMichael, MD Professor and Chair Department of Dermatology Wake
DOI /j x
THERAPEUTICS DOI 1.1111/j.1365-2133.28.8548.x Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis C. Leonardi, A. Menter,* T. Hamilton, I. Caro,à B. Xingà and
CURRICULUM VITAE East Riverside Boulevard Rockford, IL 61114
CURRICULUM VITAE Name: Present Employer: David J. Dansdill, M.D., F.A.C.R. OrthoIllinois 5875 East Riverside Boulevard Rockford, IL 61114 Date Affiliated: January 2003 Date of Birth: July 25, 1958 Place
Topical Retinoids Prior Authorization Criteria Program Summary
Topical Retinoids Prior Authorization Criteria Program Summary OBJECTIVE The intent of the Retinoids Prior Authorization (PA) criteria is to discourage use of the listed target agents for the treatment
JEADV SHORT REPORT. Abstract
DOI: 1.1111/jdv.14738 JEADV SHORT REPORT Safety and efficacy of through 14 weeks in patients with moderate to severe psoriasis who continued on or switched from etanercept treatment: findings from the
STUDY. A New Classification System for Grading the Severity of Onychomycosis
STUDY A New Classification System for Grading the Severity of Onychomycosis Onychomycosis Severity Index Caitlin Carney, MD; Antonella Tosti, MD; Ralph Daniel, MD; Richard Scher, MD; Phoebe Rich, MD; Jamie
CURRICULUM VITAE (updated August 2018)
CURRICULUM VITAE (updated August 2018) Name: Andrew Blauvelt, M.D., M.B.A. Date and Place of Birth: February 12, 1962, Ypsilanti, MI Work Address: 9495 SW Locust Street Suite G Portland, OR 97223 Phone:
(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)
Secukinumab in Psoriasis Patients with Concurrent Psoriatic Arthritis: Patient-Reported Outcomes in the Corrona Psoriasis Registry AB Gottlieb, B Strober, 2 AW Armstrong, 3 JD Greenberg, 4,5 C Karki, 4
SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84
CURRICULUM VITAE RUSSELL D'AMBRA, M.D. July 2014 North Shore Diabetes & Endocrine Associates 3003 New Hyde Park Road Suite 201 New Hyde Park, New York 11042 516-327-0850 EDUCATION: POST-GRADUATE TRAINING:
Diagnosis And Treatment Of Seborrheic Dermatitis
Diagnosis And Treatment Of Seborrheic Dermatitis 1 / 5 2 / 5 3 / 5 Diagnosis And Treatment Of Seborrheic Seborrheic dermatitis Diagnosis. Your doctor will likely be able to determine whether you have seborrheic
CUTANEOUS SENSORY THRESHOLD STIMULATION WITH HIGH FREQUENCY SQUARE-WAVE CURRENT II. THE RELATIONSHIP OF BODY SITE AND OF SKIN DISEASES TO THE SENSORY
CUTANEOUS SENSORY THRESHOLD STIMULATION WITH HIGH FREQUENCY SQUARE-WAVE CURRENT II. THE RELATIONSHIP OF BODY SITE AND OF SKIN DISEASES TO THE SENSORY THRESHOLD* HARRY SIGEL, M.D. Potelunas, Meixner and
Contents. QAaptm-2. CAaptei-3. CAaptm-4. Cftapte%-5. Qfiaptvt-6. QhapteK-7. Qkaptefc-8 Clinical Immunology and Allergy 71
Contents Ckaptm-1 Aaatomy, Physiology, Embryology, Bacteriology and Pathology ~ 1 Anatomy 1 Physiology 10 Embryology 14 Pathology 19 Bacteriology 22 Laboratory and other aids in dermatological pratice
Panel: Practice Pearls from the Pros. Prescription Medication: Office Protocols. Kathy Jones, BSN, RN, CPSN
24TH Annual Meeting Panel: Practice Pearls from the Pros Prescription Medication: Office Protocols Kathy Jones, BSN, RN, CPSN Upon completion of this presentation, the participants will self-report an
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada. Catherine Zip Nov 10, 2016
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada Catherine Zip Nov 10, 2016 Acne Acne Classification Type Comedonal Mild-to-moderate papulopustular acne Severe Description
DERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY
DERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
Dermclinic
Dermclinic /Dermclinic A Photo Quiz to Hone Dermatologic Skills DAVID L. KAPLAN, MD Series Editor University of Missouri Kansas City, University of Kansas Case 1: Upon his return from a summer visit to
75th AAD Annual Meeting
75th AAD Annual Meeting Poster nº 4873 A phase 3 randomized, double-blind, trial comparing the efficacy and safety of the fixed combination calcipotriene 0.005% (Cal) and betamethasone dipropionate 0.064%
1 Assessment Techniques General Survey Skin, Hair, and Nails. 2 Cultivating Your Senses
1 Assessment Techniques General Survey Skin, Hair, and Nails 2 Cultivating Your Senses Inspection Always performed first Palpation Purpose Use different parts of the hands Light vs. deep palpation 3 Cultivating
The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis
Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which
The lipid barrier of the Stratum Corneum
The lipid barrier of the Stratum Corneum Stratum Corneum: the "Bricks and Mortar" model Ceramides (40-65% total lipids) HN O Glucoceramides HN O O HO O cerabrosidase Cholesteryl sulphate Free fatty acids
ACNE BOOT CAMP TOPICAL THERAPY BASICS
ACNE BOOT CAMP TOPICAL THERAPY BASICS Lawrence J Green, MD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington DC Relevant Disclosures Investigator -Allergan,
TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT BENIGN SKIN GROWTHS TABLE 9 (CONTINUED) BULLOUS DISORDERS OR BLISTERING DISEASES...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 1 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR...
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept Robert Bissonnette, MD, FRCPC, a Chantal Bolduc, MD, FRCPC, a Yves Poulin, MD,
COMMON SKIN INFECTIONS. Sports Medicine
COMMON SKIN INFECTIONS Sports Medicine IMPETIGO IS A SUPERFICIAL BACTERIAL INFECTION CAUSED BY: STREPTOCOCCI OR STAPHYLOCOCCUS AUREUS BOULOUS IMPETIGO IMPETIGO COMES IN TWO FORMS: BOULOUS OR NON- BOULOUS
CONDITIONS OF THE SKIN
CONDITIONS OF THE SKIN UCSF/SFGH Family & Community Medicine Residency Program Educational Objectives I. Knowledge The resident will be able to discuss the definition, diagnosis, and initial management
PATIENT INFORMATION. RESPONSIBLE PARTY (If Different from Patient) POLICY HOLDER INFORMATION (If Different from Patient)
PATIENT INFORMATION Today s Date: Patient s Last Name: First: M.I. Mailing Address: City: State: Zip: Home Phone: ( ) Cell: ( ) Work: ( ) Date of Birth: / / Age: Sex: SSN: Driver s License #: Marital Status:
ORIGINAL INVESTIGATION. Most Common Dermatologic Problems Identified by Internists,
ORIGINAL INVESTIGATION Most Common Dermatologic Problems Identified by Internists, 1990-1994 Steven R. Feldman, MD, PhD; Alan B. Fleischer, Jr, MD; R. Carol McConnell, BS Background: Internists in all
What are the functions of the integumentary system? What are some disorders of the integumentary system?
Essential Questions: What are the functions of the integumentary system? What are some disorders of the integumentary system? How are integumentary system disorders treated? How do you relate the integumentary
KENNETH ROBERT BEER, M.D. Curriculum Vitae
KENNETH ROBERT BEER, M.D. Curriculum Vitae Date of Birth: 05-07-63, New York Office Address: 1500 North Dixie Highway, Suite 303, West Palm Beach, Florida, 33401 (561) 655-9055(office) (561) 655-9233(fax)
Rosalyn Elizabeth George M.D., FAAD
Rosalyn Elizabeth George M.D., FAAD 7 1 0 M I L I T A R Y C U T O F F R D, S U I T E 3 2 0 W I L M I N G T O N, N C 2 8 4 0 5 9 1 0-2 5 6-4 3 5 0 P H N C L I C E N S E # 2 0 0 8-0 0 0 5 4 R G E O R G E
GROUP 15 TOPICAL PREPARATIONS
- 105 - GROUP 15 15.1 DERMATOLOGICAL PREPARATIONS 15.1.1 TOPICAL ANTIFUNGALS CLOTRIMAZOLE Indication: Treatment of susceptible fungal infections, dermatophytoses, superficial mycoses, and cutaneous candidiasis
Integumentary System
Integumentary System CPT CPT copyright 2011 American Medical Association. All rights reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the
Clinical Study Synopsis for Public Disclosure
Clinical Study Synopsis for Public Disclosure These results are supplied for informational purposes only in the interest of scientific disclosure. The synopsis may include approved and non-approved uses,
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
Corporate Medical Policy
Corporate Medical Policy Dermatologic Applications of Photodynamic Therapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dermatologic_applications_of_photodynamic_therapy 10/2003
Abstract Background: Methods: Results: Conclusion:
1055 Two-Year Safety of, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Moderate to Severe Psoriasis: Results From a Phase 3, Randomized, Controlled Trial () Kim A. Papp, MD 1 ; Kristian Reich,
Subspecialty Rotation: Dermatology
Subspecialty Rotation: Dermatology Faculty: Wesley Galen, M.D. GOAL: Prevention, Counseling and Screening (Dermatology). Understand the pediatrician's role in preventing illness and dysfunction related
What s new in psoriasis? An analysis of guidelines and systematic reviews published in
Clinical dermatology Review article CED Clinical and Experimental Dermatology CPD What s new in psoriasis? An analysis of guidelines and systematic reviews published in 2009 2010 A. C. Foulkes, D. J. C.
Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada. Pathogenesis & management of acne scarring
Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada Pathogenesis & management of acne scarring Disclosures Relationships with commercial interests: Abbott Laboratories A(Grants/Research
Smoking and the Skin
Smoking and the Skin Renee Bittoun Adjunct Associate Professor University of Sydney and Notre Dame University Director: Smokers Clinics, SLAHD. Founding Editor in Chief: The Journal of Smoking Cessation
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 January 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 January 2012 EPIDUO, gel Tube of 30 g (CIP code: 383 814-6) Tube of 60 g (CIP code: 383 816-9) Applicant: GALDERMA
PROFESSIONAL MEMBERSHIPS
June 2012 January 2014 October 2009 May 2012 Staff Rheumatologist, Diagnostic Clinic, Clearwater, FL Staff Rheumatologist, Arthritis Associates, Palm Harbor, FL 2008 2012 Co-Investigator, Arthritis Research
DERMATOLOGY FOR THE NON-DERMATOLOGIST. Mackinac Island, Michigan The Grand Hotel. July 16 18, Participating Faculty
DERMATOLOGY FOR THE NON-DERMATOLOGIST Mackinac Island, Michigan The Grand Hotel July 16 18, 2010 Participating Faculty Lori D. Prok, M.D. Assistant Professor Pediatric Dermatology and Dermatopathology
Index. Angiosarcoma diagnosis, 47 lymphedema-related vs. non-lymphedemarelated, 48
A Acneiform rash biopsy, 134 cetuximab, EGFR, 132 133 diagnosis, 131 patient history, 131 134 treatment, 134 135 Acne vulgaris, 109 AGA. See Androgenetic alopecia Alopecia areata, 148 American Joint Committee
Do Not Copy Penalties Apply
October 2010 1221 Volume 9 Issue 10 Copyright 2010 Original Articles Vehicle or Placebo? Investigators Use Incorrect Terminology in Randomized Controlled Trials Half of the Time: A Systematic Review of
Dermatology Pearls. Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018
Dermatology Pearls Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018 What s on the agenda? Common skin conditions and where to start with treatment Gentle skin care regimen PCP and Biologics
Acne vulgaris is a common skin disease presenting
Efficacy and Safety of Dapsone Gel 5% for the Treatment of Acne Vulgaris in Adolescents Sharon Raimer, MD; J. Michael Maloney, MD; Marc Bourcier, MD; David Wilson, MD; Kim Papp, MD; Elaine Siegfried, MD;
the Treatment of Senile Purpura and the Prevention of Dermatoporosis October 2015 Volume 14 Issue 10 Case Report 1147 Copyright 2015
Home (http://jddonline.com) / Articles Topical Human Epidermal Growth Factor in the Treatment of Senile Purpura and the Prevention of Dermatoporosis October 2015 Volume 14 Issue 10 Case Report 1147 Copyright
Dual Wavelength Phototherapy System
Dual Wavelength Phototherapy System The AKLARUS Blue and Red Combination System is an effective, drugfree alternative for treating acne & photodamaged skin. The non-invasive Aklarus treatment has been
50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).
DUPISOR Composition Gel 50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). Action Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol
Summer AAD Summer AAD Support provided by LEO Pharma A/S. Poster nº
Support provided by LEO Pharma A/S Fixed combination calcipotriene plus betamethasone dipropionate aerosol foam provides improvement in quality of life and rapid relief of itch/itch-related sleep loss
Psoriasis is a lifelong condition, with onset
THERAPEUTICS FOR THE CLINICIAN Clobetasol Propionate Lotion in the Treatment of Moderate to Severe Plaque-Type Psoriasis Jacques Decroix, MD; Henrik Pres, MD; Nicolaï Tsankov, MD; Michel Poncet, PhD; Stéphanie
29a Pathology - Integumentary System
29a Pathology - Integumentary System 29a Pathology - Integumentary System! Class Outline 5 minutes Attendance, Breath of Arrival, and Reminders 10 minutes Lecture: 25 minutes Lecture: 15 minutes Active
15 th Annual South Beach Symposium Clinical + Aesthetic Dermatology Symposium February 9-12, 2017 Miami Beach, Florida
15 th Annual South Beach Symposium Clinical + Aesthetic Dermatology Symposium February 9-12, 2017 Miami Beach, Florida 8:00 am 7:00 pm Registration Desk Open Thursday, February 09, 2017 8:30 am 3:00 pm
forniture parafarmaceutiche
User's Manual forniture parafarmaceutiche CONTENTS forniture parafarmaceutiche Dermatitis of the Scalp Seborrheic Dermatitis Treatments Atopshield Lotion The mechanism of action of Atopshield Lotion Indications
(July 13, 2006 Denver, CO) In a community where the. higher altitude means up to 25% increased levels of harmful
DATE July 13, 2006 CONTACT General Inquiries: Kerry Parker, 1-877-WDS-ROSE (937-7673) Media Inquiries: Nancy FitzGerald (760) 333-9296 SUN SAFETY CAMPAIGN SOARS TO NEW HEIGHTS IN DENVER AS RECORD- BREAKING
Dow B. Stough, MD, CPI Curriculum Vitae
Dow B. Stough, MD, CPI Curriculum Vitae THE DERMATOLOGY CLINIC Rev. 9/26/2016 3633 Central Avenue, Suite N Hot Springs, AR 71913 (501) 623-6100 EDUCATION: Dr. Dow Stough is a renowned surgeon known for
MAZE MEN S SEXUAL & REPRODUCTIVE HEALTH CURRICULUM VITAE
MAZE MEN S SEXUAL & REPRODUCTIVE HEALTH CURRICULUM VITAE NAME Michael A. Werner, M.D. TITLE Medical Director, Maze Sexual & Reproductive Health Board certified urologist with practice limited to Sexual
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
TruGen3 Tru Derma Health, Justin Vujevich, M.D. The High Risk Skin Cancer Patient. Skin Cancer, Detection, and Prevention
TruGen3 Tru Derma Health, Justin Vujevich, M.D. The High Risk Skin Cancer Patient As a case example, Robert is a 65 year-old retired engineer who presented to his dermatologist with a non-healing, growing
My Algorithm. Questions to ask. Do you or your family have a history of?... Allergic rhinitis, Sensitive skin, Asthma Skin Cancer
Tracey C. Vlahovic, DPM Associate Professor, Temple University School of Podiatric Medicine My Algorithm Inflammatory Skin Disorder on Feet Family hx, clinical exam, look at hands! Defined plaques: Psoriasis
Prevalence of Geriatric Dermatosis A Study
Original Research Article Prevalence of Geriatric Dermatosis A Study A. Padma 1, D. Sudhavani 1, M. Shahana 1*, N. Bhavana 2, G. Narsimharao Netha 3 1 Assistant Professor, 3 Professor and HOD Department
Staying A- Head in Pediatric Dermatology:
Staying A- Head in Pediatric Dermatology: Common Scalp and Hair Diagnoses Matt Grisham, MD Greenville Health System Post-Graduate Seminar April 20, 2016 I have no financial disclosures or conflicts of
Curriculum Vitae, Michael A. Hassman, D.O.
CONTACT INFORMATION: Michael A. Hassman, D.O. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009 Site Selection and Information: Bobbie Theodore, Alliance
Curriculum Vitae, Michael A. Hassman, D.O.
CONTACT INFORMATION: Michael A. Hassman, D.O. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009 Site Selection and Information: Bobbie Theodore, Alliance
Tinea: Head to Toe A dermatophyte tour of human skin. Tour de Tinea Head to Toe. Tips for Tinea Head to Toe. Psoriasis. Non-inflammatory Tinea Capitis
Tinea: Head to Toe A dermatophyte tour of human skin Renee Howard, MD Assistant Clinical Professor of Dermatology, UCSF Tour de Tinea Head to Toe Tips for Tinea Head to Toe Capitis Faciei Corporis Pedis
Doxycycline/Minocycline Step Therapy Criteria Program Summary
This criteria applies to Commercial, NetResults F series and Health Insurance Marketplace formularies. OBJECTIVE The intent of the Doxycycline/Minocycline Step Therapy (ST) program is to encourage the
Site and distribution: symmetrical, asymmetrical. Surface characteristics: smooth, scaly, warty
B I O T E R R O R I S M PRINCIPLES AND PRACTICE OF DERMATOLOGY Dr Matthew Ng Joo Ming INTRODUCTION Medical schools and textbooks teach us dermatology by subjects such as eczema and psoriasis. This is useful
Clinical Policy: Benign Skin Lesion Removal Reference Number: CP.MP.HN150
Clinical Policy: Reference Number: CP.MP.HN150 Effective Date: 6/04 Last Review Date: 8/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
Comorbid skin diseases in psoriasis results of nationwide occupational skin screenings - master thesis -
Hamburg University of Applied Sciences Faculty of Life Sciences Master of Health Sciences Comorbid skin diseases in psoriasis results of nationwide occupational skin screenings - master thesis - In collaboration
Clinic Clinic Information Suitable for Referral Not Suitable for Referral
PBC Services Clinic Clinic Information Suitable for Referral Not Suitable for Referral Diabetes One Off Clinic Donnington Medical The Health Centre, Wrekin Drive Donnington TF2 8EA Contact: Bryan Henshall
Recalcitrant Warty Erythroderma With Severe Pruritus. Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University
Recalcitrant Warty Erythroderma With Severe Pruritus Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University DISCLOSURE OF RELEVANT RELATIONSHIPS WITH INDUSTRY Gil Yosipovitch,
TOPICAL TREATMENT OF ACTINIC KERATOSIS
TOPICAL TREATMENT OF ACTINIC KERATOSIS Gary Goldenberg, MD Goldenberg Dermatology, PC Assistant Clinical Professor of Dermatology The Icahn School of Medicine at Mount Sinai Hospital Conflicts of Interest
Geriatric Dermatoses in Benghazi, Libya
Research DOI: 10.6003/jtad.1593a1 Geriatric Dermatoses in Benghazi, Libya Safa Suleman Elfaituri, MD Address: Dermatology Department, Medical Faculty, Benghazi University, Jumhoria Hospital, Benghazi,
CURRICULUM VITAE (updated January 2017)
CURRICULUM VITAE (updated January 2017) Name: Andrew Blauvelt, M.D., M.B.A. Date and Place of Birth: February 12, 1962, Ypsilanti, MI Work Address: 9495 SW Locust Street Suite G Portland, OR 97223 Phone:
PFIZER INC. GENERIC DRUG NAME and/or COMPOUND NUMBER: 5% Spironolactone Cream/ PF
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.